United Therapeutics Corp (FRA:UTH)
€ 245.3 4.6 (1.91%) Market Cap: 10.88 Bil Enterprise Value: 8.92 Bil PE Ratio: 12.50 PB Ratio: 2.19 GF Score: 89/100

United Therapeutics Corp Annual Shareholders Meeting Transcript

Jun 26, 2020 / 02:15PM GMT
Release Date Price: €110 (+2.80%)
Paul A. Mahon
United Therapeutics Corporation - Executive VP, General Counsel & Corporate Secretary

Welcome to the 2020 Annual Meeting of Shareholders of United Therapeutics Corporation, and happy 24th birthday to United Therapeutics, born today at exactly high noon. This is the first time in our history that we are holding our annual meeting virtually. My name is Paul Mahon. I'm United Therapeutics' General Counsel and Corporate Secretary.

Let me introduce some of those who are present at this meeting. We have Dr. Martine Rothblatt, our Chairman and Chief Executive Officer; Michael Benkowitz, our President and Chief Operating Officer; James Edgemond, our Chief Financial Officer and Treasurer; and John Hess, our Deputy General Counsel and Assistant Corporate Secretary.

We also have several members of our Board of Directors with us this morning, including Christopher Causey, the Chairman of the Compensation Committee at United Therapeutics. Finally, we have Dan Kotter and Saralyn Woodruff, representing our independent audit firm, Ernst & Young. I am also joined by [Jim Raitt]

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot